{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:00:03Z","timestamp":1776099603967,"version":"3.50.1"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,27]]},"abstract":"<jats:p>\n                    This study aims to evaluate the association between the timing of low-dose aspirin (LDA) initiation in the first trimester and obstetric outcomes, including uterine artery pulsatility index (UtA PI), fetal growth parameters, pregnancy-associated plasma protein-A (PAPP-A) levels, and delivery outcomes in a high-risk population for preeclampsia (PE). This prospective cohort study compared pregnant women at high risk for PE who initiated LDA before 11 weeks of gestation (early aspirin group) with those who initiated LDA between 11 and 14 weeks (late aspirin group). Outcomes included first- and second-trimester UtA PI measurements, PAPP-A multiples of median values, estimated fetal weight, fetal growth restriction, preterm birth, and delivery characteristics. Among 1062 pregnant women evaluated, 139 met the inclusion criteria; 55 initiated LDA before 11 weeks and 50 between 11 and 14 weeks of gestation. At least one high-risk factor for PE was present in 43.8% of participants, while more than 96% had at least one moderate-risk factor. PE developed in 3 cases (one in the early group and 2 in the late group). Mean PAPP-A multiples of median values at 11 to 14 weeks were significantly higher in the early aspirin group. No statistically significant differences were observed between groups in UtA PI values at either 11 to 14 or 20 to 24 weeks of gestation. Within the early aspirin group, women who delivered preterm had significantly higher mean UtA PI and UtA PI percentile values at 20 to 24 weeks compared with those who delivered at term (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.003 and\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.007, respectively). Early initiation of LDA before 11 weeks of gestation was associated with higher first-trimester PAPP-A levels but was not associated with significant differences in uterine artery Doppler indices or major obstetric outcomes at the group level. Elevated UtA PI values were consistently associated with adverse pregnancy outcomes, independent of aspirin initiation timing, suggesting that uterine artery Doppler parameters more likely reflect the severity of underlying placental pathology rather than a treatment-related effect. Given the low incidence of PE and fetal growth restriction in the study population, the study may be underpowered for definitive conclusions regarding clinical outcomes; therefore, the findings should be interpreted cautiously and considered hypothesis-generating.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047867","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T01:00:33Z","timestamp":1772240433000},"page":"e47867","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effect of first-trimester aspirin initiation timing on obstetric outcomes: A comparative study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6845-9991","authenticated-orcid":false,"given":"Bilge","family":"Cetinkaya Demir","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ediz","family":"G\u00fcney","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mudanya Goverment Hospital, Bursa, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokhan","family":"Ocakoglu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Bursa Uludag University, Bursa Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260413","doi-asserted-by":"crossref","first-page":"119922","DOI":"10.1016\/j.cca.2024.119922","article-title":"Preeclampsia: a comprehensive review.","volume":"563","author":"Ali","year":"2024","journal-title":"Clin Chim Acta"},{"key":"R2-20260413","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(16)31470-2","article-title":"Global, regional, and national levels of maternal mortality, 1990\u20132015: a systematic analysis for the global burden of disease study 2015.","volume":"388","author":"Kassebaum","year":"2016","journal-title":"The Lancet"},{"key":"R3-20260413","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2215\/CJN.12081115","article-title":"Preeclampsia: updates in pathogenesis, definitions, and guidelines.","volume":"11","author":"Phipps","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-20260413","doi-asserted-by":"crossref","first-page":"1144170","DOI":"10.3389\/fmed.2023.1144170","article-title":"Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum.","volume":"10","author":"Bisson","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"Suppl 1","key":"R5-20260413","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention.","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstetrics"},{"key":"R6-20260413","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20260413","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia.","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"R8-20260413","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.2017.3439","article-title":"Screening for preeclampsia: US preventive services task force recommendation statement.","volume":"317","author":"Bibbins-Domingo","year":"2017","journal-title":"JAMA"},{"key":"R9-20260413","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0028-2243(93)90265-E","article-title":"A high uterine artery pulsatility index reflects a defective development of placental bed spiral arteries in pregnancies complicated by hypertension and fetal growth retardation.","volume":"49","author":"Olofsson","year":"1993","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R10-20260413","doi-asserted-by":"crossref","first-page":"612.e1","DOI":"10.1016\/j.ajog.2018.02.014","article-title":"Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit.","volume":"218","author":"Wright","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20260413","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/uog.26222","article-title":"ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy.","volume":"61","author":"Rolnik","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R12-20260413","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia:a meta-analysis of individual patient data.","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"R13-20260413","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ajog.2019.08.047","article-title":"Does low-dose aspirin initiated before 11 weeks\u2019 gestation reduce the rate of preeclampsia?","volume":"222","author":"Chaemsaithong","year":"2020","journal-title":"ACOG"},{"key":"R14-20260413","first-page":"e237","article-title":"Gestational hypertension and preeclampsia.","volume":"6","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R15-20260413","first-page":"e44","article-title":"Low dose aspirin use during pregnancy.","volume":"1","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R16-20260413","first-page":"6","article-title":"Hypertension in pregnancy: diagnosis and management.","year":"2019","journal-title":"NICE guideline"},{"key":"R17-20260413","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ogc.2021.02.002","article-title":"Abnormal fetal growth: small for gestational age, fetal growth restriction, large for gestational age: definitions and epidemiology.","volume":"48","author":"Damhuis","year":"2021","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R18-20260413","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/uog.5157","article-title":"Uterine artery Doppler at 11\u2009+\u20090 to 13\u2009+\u20096 weeks in the prediction of pre-eclampsia.","volume":"30","author":"Plasencia","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R19-20260413","doi-asserted-by":"crossref","first-page":"100521","DOI":"10.1016\/j.xagr.2025.100521","article-title":"Prediction of preeclampsia before 11th week of gestation: a secondary analysis of the ASPIRIN trial.","volume":"5","author":"Capdeville","year":"2025","journal-title":"AJOG Global Rep"},{"key":"R20-20260413","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12785","article-title":"Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies.","volume":"79","author":"Quao","year":"2018","journal-title":"Am J Reprod Immunol"},{"key":"R21-20260413","doi-asserted-by":"crossref","first-page":"S829","DOI":"10.1016\/j.ajog.2017.11.565","article-title":"The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.","volume":"218","author":"Groom","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20260413","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N Engl J Med"},{"key":"R23-20260413","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1177\/1933719117698574","article-title":"Preterm delivery as a unique pathophysiologic state characterized by maternal soluble FMS-like tyrosine kinase 1 and uterine artery resistance during pregnancy: a longitudinal cohort study.","volume":"24","author":"Straughen","year":"2017","journal-title":"Reprod Sci"},{"key":"R24-20260413","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"key":"R25-20260413","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","article-title":"National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications.","volume":"379","author":"Blencowe","year":"2012","journal-title":"Lancet"},{"key":"R26-20260413","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/uog.24915","article-title":"Routine first-trimester pre-eclampsia screening and risk of preterm birth.","volume":"60","author":"Giorgione","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R27-20260413","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/AOG.0000000000001848","article-title":"Antiplatelet agents and the prevention of spontaneous preterm birth: a systematic review and meta-analysis.","volume":"129","author":"van Vliet","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R28-20260413","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/JPM.2006.089","article-title":"Normal and abnormal transformation of the spiral arteries during pregnancy.","volume":"34","author":"Espinoza","year":"2006","journal-title":"J Perinat Med"},{"key":"R29-20260413","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3109\/14767058.2014.927860","article-title":"The impact of platelet functions and inflammatory status on the severity of preeclampsia.","volume":"28","author":"Sahin","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R30-20260413","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1469-0705.1994.04050391.x","article-title":"Color Doppler imaging of the uteroplacental circulation in the middle trimester: observations on the development of a low resistance circulation.","volume":"4","author":"Fay","year":"1994","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R31-20260413","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1503\/cmaj.070430","article-title":"Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a system- atic review and bivariable meta-analysis.","volume":"178","author":"Cnossen","year":"2008","journal-title":"CMAJ"},{"issue":"Suppl","key":"R32-20260413","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/uog.15593","article-title":"Does low dose aspirin effect mean uterine artery Doppler pulsatility index in women deemed high risk for early pre-eclampsia?","volume":"46","author":"Leduc","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R33-20260413","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers.","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"R34-20260413","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/pd.2930","article-title":"Screening for pre-eclampsia by using changes in uterine artery Doppler indices with advancing gestation.","volume":"32","author":"Napolitano","year":"2012","journal-title":"Prenat Diagn"},{"key":"R35-20260413","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/pd.4403","article-title":"Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation.","volume":"34","author":"Bujold","year":"2014","journal-title":"Prenat Diagn"},{"key":"R36-20260413","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1067\/S0002-9378(03)00838-X","article-title":"Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes.","volume":"189","author":"Kim","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R37-20260413","doi-asserted-by":"crossref","first-page":"S895","DOI":"10.1016\/j.ajog.2020.09.026","article-title":"Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia.","volume":"226","author":"Staff","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R38-20260413","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1055\/s-0038-1677476","article-title":"Evaluation of the effect of low-dose aspirin on biochemical and biophysical biomarkers for placental disease in low-risk pregnancy: sec- ondary analysis of a multicenter RCT.","volume":"36","author":"Mone","year":"2019","journal-title":"Am J Perinatol"},{"key":"R39-20260413","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.preghy.2018.04.003","article-title":"The effect of low-dose aspirin on serum placental growth factor levels in a high-risk PREDO cohort.","volume":"13","author":"Murtoniemi","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"R40-20260413","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.preghy.2022.10.009","article-title":"Short communication: Is there any benefit of initiating aspirin before the 11th week of gestation?","volume":"30","author":"Ghesquiere","year":"2022","journal-title":"Pregnancy Hypertension"},{"key":"R41-20260413","doi-asserted-by":"crossref","first-page":"69","DOI":"10.18502\/ijrm.v22i1.15244","article-title":"Aspirin administration from early pregnancy versus initiation after 11 weeks of gestation for prevention of pre-eclampsia in high-risk pregnant women: Study protocol for randomized controlled trial.","volume":"22","author":"Hantoushzadeh","year":"2024","journal-title":"Int J Reprod BioMedicine (IJRM)"},{"key":"R42-20260413","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.ajog.2004.10.598","article-title":"Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study.","volume":"192","author":"Norgard","year":"2005","journal-title":"Am J Obstet Gynecol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:01:17Z","timestamp":1776096077000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047867","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"2025-10-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}